Osteocyte: The unrecognized side of bone tissue

INSERM Research Unit 658, Centre Hospitalier Régional, 1 rue Porte Madeleine, 45 032 Orleans, France.
Osteoporosis International (Impact Factor: 4.17). 03/2010; 21(9):1457-69. DOI: 10.1007/s00198-010-1194-5
Source: PubMed


Osteocytes represent 95% of all bone cells. These cells are old osteoblasts that occupy the lacunar space and are surrounded by the bone matrix. They possess cytoplasmic dendrites that form a canalicular network for communication between osteocytes and the bone surface. They express some biomarkers (osteopontin, β3 integrin, CD44, dentin matrix protein 1, sclerostin, phosphate-regulating gene with homologies to endopeptidases on the X chromosome, matrix extracellular phosphoglycoprotein, or E11/gp38) and have a mechano-sensing role that is dependent upon the frequency, intensity, and duration of strain.
The mechanical information transmitted into the cytoplasm also triggers a biological cascade, starting with NO and PGE2 and followed by Wnt/β catenin signaling. This information is transmitted to the bone surface through the canalicular network, particularly to the lining cells, and is able to trigger bone remodeling by directing the osteoblast activity and the osteoclastic resorption. Furthermore, the osteocyte death seems to play also an important role. The outcome of micro-cracks in the vicinity of osteocytes may interrupt the canalicular network and trigger cell apoptosis in the immediate surrounding environment. This apoptosis appears to transmit a message to the bone surface and activate remodeling. The osteocyte network also plays a recognized endocrine role, particularly concerning phosphate regulation and vitamin D metabolism. Both the suppression of estrogen following menopause and chronic use of systemic glucocorticoids induce osteocyte apoptosis. On the other hand, physical activity has a positive impact in the reduction of apoptosis. In addition, some osteocyte molecular elements like sclerostin, connexin 43, E11/gp38, and DKK1 are emerging as promising targets for the treatment of various osteo-articular pathologies.

Download full-text


Available from: Gaël Y Rochefort
  • Source
    • "PTH at a low concentration of calcium stimulates osteoclasts, resulting in bone resorption. Calcitonin, which is an antagonist of PTH, and estrogens, can easily inhibit the action of osteoclasts [6] [7] [26] [29]. Many forms of bone disorders are well known. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Various forms of bony deformations and dysplasias are often present in the facial skeleton. Bone defects can be either localized or general. Quite often they are not only present in the skull but also can be found in other parts of the skeleton. In many cases the presence and levels of specific bone markers should be measured in order to fully describe their activity and presence in the skeleton. Fibrous dysplasia (FD) is the most common one in the facial skeleton; however, other bone deformations regarding bone growth and activity can also be present. Every clinician should be aware of all common, rare and uncommon bony diseases and conditions such as cherubism, Paget's disease, osteogenesis imperfecta and others related to genetic conditions. We present standard (calcium, parathyroid hormone, calcitonin, alkaline phosphatase, vitamin D) and specialized bone markers (pyridinium, deoxypyridinium, hydroxyproline, RANKL/RANK/OPG pathway, growth hormone, insulin-like growth hormone-1) that can be used to evaluate, measure or describe the processes occurring in craniofacial bones.
    Full-text · Article · Nov 2015 · Postępy Higieny i Medycyny Doświadczalnej (Advances in Hygiene and Experimental Medicine)
  • Source
    • "L. Spiegelberg et al. / Journal of Cranio-Maxillo-Facial Surgery 43 (2015) 214e219 217 Osteocytes derive from osteoblasts that have become 'trapped' in the matrix that they have produced themselves. They maintain contact with each other and with the osteoblasts and osteoclasts that reside at the bone surface by cytoplasmic extensions called dendrites, that extend into channels in the matrix (Rochefort et al., 2010). In this way, osteocytes send signals for bone resorption and formation to osteoclasts and osteoblasts, respectively, and therefore play an essential role in bone maintenance and remodelling (Bonewald, 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Radiation therapy (RT) as part head and neck cancer treatment often leads to irradiation of surrounding normal tissue, such as mandibular bone. A reduced reparative capacity of the bone can lead to osteoradionecrosis (ORN). Hyperbaric oxygen therapy (HBOT) is used to treat ORN, based on its potential to raise the oxygen tension in tissues. However, prevention of radiation-induced damage is of great interest. Our purpose was to investigate whether HBOT could prevent radiation-induced damage to murine mandibles.Methods Twenty-eight mice were irradiated in the head and neck region with a single dose (15 Gy) and half of them were subsequently subjected to HBOT. Another 14 mice did not receive any treatment and served as controls. Ten and 24 weeks after RT, mandibles were harvested and analysed histologically and by microcomputed tomography (micro-CT).ResultsMicro-CT analysis showed a reduction in relative bone volume by RT, which was partly recovered by HBOT. Trabecular thickness and separation were also positively influenced by HBOT. Morphologically, HBOT suppressed the osteoclast number, indicating decreased resorption, and decreased the amount of lacunae devoid of osteocytes, indicating increased bone viability.ConclusionsHBOT was able to partly reduce radiation-induced effects on microarchitectural parameters, resorption, and bone viability in mouse mandibles. HBOT could therefore potentially play a role in the prevention of radiation-induced damage to human mandibular bone.
    Full-text · Article · Nov 2014 · Journal of Cranio-Maxillofacial Surgery
  • Source
    • "This result is similar to studies involving postmenopausal women and men concluding that there are correlations among body weight, muscle mass, and osteoporosis (10, 18, 19, 20). It can be explained that body weight acts as a stress on the skeletal system to promote bone formation mechanically by stimulating osteocytes to increase bone density (21), and muscle mass, like fat mass may have a protective effect on bone density through hormones (22). Also, the association between greater muscle mass and greater bone density is likely to be determined by multiple factors including common nutrition, life style and genes regulating size (23, 24). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study was to predict osteoporosis risk as decreasing muscle mass and to declare the cut-off value of low muscle mass in an elderly Korean population. This study was based on data from the 2008-2010 Korea National Health and Nutritional Examination Surveys (KNHANES). The subjects included 1,308 men and 1,171 women over 65 yr. Bone mineral density (BMD) and appendicular skeletal muscle (ASM) were measured by dual energy X-ray absorptiometry (DXA), and appendicular skeletal muscle was adjusted by height as a marker of sarcopenia. After confirming the correlation between low muscle mass and BMD, the best cut-off value of muscle mass to estimate osteoporosis was suggested through the receiver operating characteristic (ROC) curve. For both men and women, BMD correlated positively with low muscle mass when ASM/Ht(2) was used as a marker for sarcopenia. The ROC curve showed that ASM/Ht(2) was the best marker for osteoporosis at a cut-off value of 6.85 kg/m(2) for men and 5.96 kg/m(2) for women. When these cut-off values were used to determine sarcopenia, the risk of osteoporosis increased 4.14 times in men and 1.88 times in women. In particular, men (OR 2.12) with sarcopenia were more greatly affected than women (OR 1.15), even after adjusting for osteoporosis risk factors. In elderly Korean people, sarcopenia is positively correlated with BMD and there is a strong correlation between sarcopenia and osteoporosis with risk of bone fracture.
    Full-text · Article · Jul 2014 · Journal of Korean Medical Science
Show more